Article

Reduced CD38 expression on CD34+ cells as a diagnostic test in myelodysplastic syndromes.

Department of Haematology, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, Oxford, UK.
Haematologica (Impact Factor: 5.87). 09/2009; 94(8):1160-3. DOI: 10.3324/haematol.2008.004085
Source: PubMed

ABSTRACT Diagnosis of myelodysplastic syndrome can be difficult especially in cases with a low blast count and a normal karyotype. Flow cytometry has been used to distinguish myelodysplastic syndrome from non-clonal cytopenias. No one single simple flow cytometric parameter has been proposed to be diagnostic of myelodysplastic syndrome. We have studied samples from 100 myelodysplastic syndrome patients and as control samples; 70 non-clonal cytopenias, 5 subjects with normal hematology, 31 patients with acute myeloid leukemia and 11 with chronic myelomonocytic leukemia or myeloproliferative disorder. We show that reduced relative mean fluorescence of CD38 below a threshold value on CD34(+) cells diagnosed low-grade myelodysplastic syndrome with 95% sensitivity (95% confidence interval, 87-99%) and 92% specificity (95% confidence interval, 82-97%). This simple flow cytometric test may be of value in the routine clinical diagnosis of myelodysplastic syndrome, especially in cases with a low blast count and normal karyotype.

Download full-text

Full-text

Available from: Mark Drayson, Jul 08, 2015
0 Followers
 · 
92 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective and subjective measures were obtained for a 4-band, 16-kbit/s sub-band coder utilizing adaptive quantizers with fixed and dynamic bit allocations. Objective measures indicated that block quantization (block companded PCM with a Gaussian probability density function, BCPCM-G) with dynamic bit allocation is slightly better than an adaptive differential PCM with a variable predictor (ADPCM-V) and fixed bit allocation, but outperforms ADPCM with a fixed predictor and fixed bit allocation (ADPCM-F) by 4-5 dB. Subjective measures, however, indicated that ADPCM-V has about 6-dB advantage over BCPCM-G. A comparison between ADPCM-V and ADPCM-F indicated that adaptive prediction provides a 4-5 dB objective gain and 16-dB subjective gain over fixed prediction. Further, all listeners preferred ADPCM-V over BCPCM-G and ADPCM-F, and 85% preferred BCPCM-G over ADPCM-F.
    Acoustics, Speech, and Signal Processing, IEEE International Conference on ICASSP '82.; 06/1982
  • Source
    Haematologica 09/2009; 94(8):1041-3. DOI:10.3324/haematol.2009.007682 · 5.87 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This article reviews the use of aberrant antigen expression detected by flow cytometry in the diagnosis and clinical handling of acute myeloid leukaemia (AML) and the myelodysplastic syndromes (MDS). Such aberrancies offer a valuable tool for the proper classification of these myeloid malignancies according the World Health Organization 2008 classification. Aberrant antigen expression by flow cytometry is also important for prognostification. This review supports the view, that minimal residual disease detection methods that make use of such aberrancies should be part of the routine management of AML patients to guide therapy, but also suggests the introduction of flow cytometry in MDS for diagnosis and treatment decisions in the near future.
    British Journal of Haematology 03/2011; 153(4):421-36. DOI:10.1111/j.1365-2141.2011.08595.x · 4.96 Impact Factor